An introduction of 3 special lenses that hit the market recently.
In the past year or so, a great deal has actually happened on the planet of contact lenses. Many new choices were authorized by the FDA and/or released. Manufacturers broadened their lens specifications. One manufacturer reported phase 3 clinical trial results of an investigational antihistamine-releasing contact lens, which could be path breaking. Other scientists are working to develop a lens that can deliver medication. And there’s more. In this short article, we review three special lenses that were released in 2019 (Table) and offer ideas on each.
A LIGHT-ADAPTIVE LENS
Voted among the 50 finest innovations of 2018 by Time, Acuvue Oasys with Transitions was introduced in April. The lens is laid on the backbone of the highly successful Acuvue Oasys lens. What sets it apart is that it contains Transitions Light Intelligent Technology, which is a big improvement over the earlier version. Like Transitions glasses, the Contact lens is designed to swiftly and flawlessly respond to changing light problems while lowering direct exposure to intense light inside home and outside home. Offered in powers from +8.00 to -12.00 D, and also in 2 base contours, the lens is a distinct enhancement to current offerings.
Not just does Acuvue Oasys with Transitions allow us to shield our patients from unsafe UV and blue light; it also provides a possibility to start a discussion with clients that play outdoor sports or that are light sensitive. Whenever patients points out that she or he is an outdoors enthusiast or fights with light sensitivity, doctors may recommend Acuvue Oasys with Transitions.
Reminding patients about the relevance of defence from hazardous UV and blue light is a win for optometry, yet don’t fail to remember to educate patients that these lenses are not a replacement for sunglasses, as they do not totally cover the eyes as well as surrounding skin.
A MULTIFOCAL TORIC
Before now, presbyopic patients with astigmatism needed to use custom-ordered contact lenses or compromise their vision results, but not any longer. Ultra-Multifocal for Astigmatism is the initial multifocal toric contact lens offered as a typical offering in the eye treatment expert’s clinic. The brand-new lens is built on the foundation of Ultra for Astigmatism and also Ultra for Presbyopia. It features the Ultra for Astigmatism’s OpticAlign style as well as Ultra for Presbyopia’s 3-Zone Progressive design.
Because of this, the Ultra Multifocal for Astigmatism boasts smooth vision in any distance and also a stable fit for consistent outcomes. It additionally consists of Ultra’s MoistureSeal technology. The lens is available in powers from +4.00 to -6.00 D with 2 add powers as well as 3 cylindrical powers. Eye doctors now expect talking to patients that have both presbyopia and astigmatism, rather than fearing discussing with them that they are not prospects for conventional soft multifocal contact lenses. No more do eye care professionals need to really feel restricted to providing monovision soft contact lenses for astigmatism with readers over top or masking astigmatism with soft multi-focals.
A daily in a brand-new material
The spherical daily disposable market is currently a crowded one, however Precision1 is being marketed as a daily disposable silicone hydrogel lens that is much more affordable than Dailies Total1 as well as more comfortable than Dailies AquaComfort Plus and also comparable hydrogel lenses.
Released in September, Precision1 is made from a new material, verofilcon A. It features 1 UV barring as well as SmartSurface technology, a permanent micro-thin high-performance layer of moisture at the lens surface that helps support a stable tear film to provide enduring visual efficiency and performance. The contact lens is offered with a 8.3 mm base contour as well as in powers from +8.00 to -12.00 D.
Although we anticipate that it will certainly be comparable to the Clariti1 day lens.
Don’t lag behind
It’s an amazing time to be an eye care professional and to fit and also prescribe contact lenses. As lens technologies continue to progress, we’re going to see even more new options hit the market. As a matter of fact, the FDA also authorized the MiSight1 day contact lens, which is shown to slow the development of myopia in kids in between the ages of 8 and 12 years.
With disruptive technologies and also direct-to-consumer contact lens companies spreading out combined messages online, it’s in the eye doctors’ benefit to stay up to date so we can best meet the needs of our patients.